(Q67920209)
Statements
A clinical evaluation of monoclonal (CA19-9, CA50, CA12-5) and polyclonal (CEA, TPA) antibody-defined antigens for the diagnosis of pancreatic cancer (English)
L Benini
G Cavallini
D Zordan
P Rizzotti
L Rigo
G Brocco
L Perobelli
M Zanchetta
P Pederzoli
1 January 1988